Melanoma and Skin Cancer Conditions We Treat

We treat all types of melanoma and skin cancer conditions at the Orlando Health Cancer Institute. Our team has caring experts who have experience helping patients from early-stage to advanced-stage cancer.

We also provide monitoring and ongoing care if you are at a higher risk of developing melanoma or skin cancer because of family history, previous personal history, genetics, abnormal moles or other conditions. We want to help you stay healthy.

We treat the following conditions:

• Pre-cancerous lesions
• Basal cell carcinomas
• Squamous cell carcinomas
• Melanoma
• Mucosal and uveal melanomas
• Merkel cell carcinoma
• Metastatic cancer of the skin
• Skin lymphomas

Treatments We Offer for Melanoma and Skin Cancer

We use advanced imaging and other tools to give you an accurate diagnosis and start the treatment process faster. Our specialists continue to get training in the latest technology to stay at the top of their field, so we can help you better.

We also have multidisciplinary tumor board meetings to help providers across multiple specialties collaborate, discuss and determine the best treatment possible.

We offer the following treatments:

• Topical medicines
• Cryosurgery
• Phototherapy
• Surgery
• Radiation therapy
• Chemotherapy
• Immunotherapy, including adoptive cell transfer with tumor infiltrating lymphocytes (TIL)
• Targeted therapy
• Access to promising clinical trials

Adoptive Cell Transfer with TIL

We offer different immunotherapy treatments to fit your needs. The Orlando Health Cancer Institute is also one of only two locations in Florida to offer adoptive cellular therapy with tumor infiltrating lymphocytes (TIL), which is a specific type of immunotherapy treatment. TIL uses your own cells from tumors to fight cancer.

If surgery and other treatments are not enough to cure your cancer, TIL provides another option. Cancer-fighting immune cells are removed from your tumors and multiplied in a lab. You receive an infusion of the cells so they can attack the cancer cells while leaving healthy cells alone.